On Your MARCKS…Get Set…Go: The Race to Explore Myristoylation in HF Is Underway
- PMID: 38094683
- PMCID: PMC10714165
- DOI: 10.1016/j.jacbts.2023.08.007
On Your MARCKS…Get Set…Go: The Race to Explore Myristoylation in HF Is Underway
Keywords: N-myristoylation; cardiac remodeling; gene therapy; heart failure; posttranslational modifications.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jacbts.2023.06.006
References
-
- Hartwig J.H., Thelen M., Rosen A., Janmey P.A., Nairn A.C., Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature. 1992;356(6370):618–622. - PubMed
-
- Duronio R.J., Towler D.A., Heuckeroth R.O., Gordon J.I. Disruption of the yeast N-myristoyl transferase gene causes recessive lethality. Science. 1989;243(4892):796–800. - PubMed
-
- Gao J., Shao K., Chen X., et al. The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation. J Mol Cell Cardiol. 2020;138:49–58. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous